Anonymous
Guest
Anonymous
Guest
This drug is a dog, management is scrambling, and nobody seems to care. Does anyone else feel the end is near?
I agree with you that management is going nutz, 35% from PCP come on !! I would rather sell Welchol or Azor than this drug. I think if anything were to happen, it will happen in August after next quarters sales #!
Selling a stent only...dangerous drug to PCP is not only wrong,immoral and inappropriate...it is dangerous..DSI/Lilly are the scum of the industry. I am out of here, doctors look at me like WTF when I talk about Effient...I can't do it...you have to draw the line....I am only selling Benicar till I can find a job
When Plavix was launched (as compared against aspirin) there were no "managed care" or "prior authorization" issues. Be patient, as there is a place in the market for Effient. Don't forget that 30% - 60% of Plavix patients are non-responders.
When Plavix was launched (as compared against aspirin) there were no "managed care" or "prior authorization" issues. Be patient, as there is a place in the market for Effient. Don't forget that 30% - 60% of Plavix patients are non-responders.
WOW, maybe this is why our sales are anemic. Listen up office based rep...we DO NOT save lives over plavix nor is there any data to suggest that...that equation was equivalent. Read your materials first before you speak up.
I love the 30% to 60% nonresponders to Plavix statement. If that's what you're telling your docs, no wonder they're not using prasugrel. Do you really believe that a doctor would continue to use a drug if they believe that half their patients won't get any benefit from the drug? Patients would be coming back with MI's, stent thrombosis, etc. all the time but it just doesn't happen. Don't believe all the marketing bullshit and hype.
If you all are so worried and there is all this talk about hemlock, kool-aid and such--why not pop a couple of Effient samples? Goodbye cruel world...
Word is that "specialty" will be the first to go when cuts are made.
When Plavix was launched (as compared against aspirin) there were no "managed care" or "prior authorization" issues. Be patient, as there is a place in the market for Effient. Don't forget that 30% - 60% of Plavix patients are non-responders.
Well said!! Yes doctor please switch those patients over to effient so they can bleed...nevermind your clinical experience. Listen to me and my shiny detail piece! OOOOHHH Pretty green color!!!!!!
I don't see why you are all being so negative... Remember that Rome wasn't built over-night. With the economy the way it is, this drug will just be a little slower than expected upon climbing to the 2-3 billion dollar a year range. After all, we have much superior efficacy to Plavix and Effient will save many, many lives so it is well worth the premium price... Think about it, what is your life worth to you?